Alimentary Pharmacology & Therapeutics
© John Wiley & Sons Ltd
Edited By: R. E. Pounder and N. J. Talley, J. M. Rhodes, J-F. Colombel, P. C. Hayes, A. C. Ford, C. W. Howden, G. M. Dusheiko, R. Loomba and A. L. Hart
Impact Factor: 5.727
ISI Journal Citation Reports © Ranking: 2014: 9/76 (Gastroenterology & Hepatology); 14/254 (Pharmacology & Pharmacy)
Online ISSN: 1365-2036
FREE: Editor's Oesophagus Collection
Key Oesophagus papers, updated July 2015
Click below for FREE access to the latest Oesophagus articles in Alimentary Pharmacology & Therapeutics.
Proton pump inhibitor use may not prevent high-grade dysplasia and oesophageal adenocarcinoma in Barrett's oesophagus: a nationwide study of 9883 patients
F. Hvid-Jensen et al. (Volume 39, Issue 9, Pages 984 – 991).
Eosinophilic oesophagitis and proton pump inhibitor-responsive oesophageal eosinophilia have similar clinical, endoscopic and histological findings
F. J. Moawad et al. (Volume 39, Issue 6, Pages 603 – 608).
Systematic review: the use of proton pump inhibitors and increased susceptibility to enteric infection
C. Bavishi & H. L. DuPont (Volume 34, Issue 11-12, Pages 1269 – 1281).
Meta-analysis: insulin resistance and sustained virological response in hepatitis C
M. Eslam et al. (Volume 34, Issue 3, Pages 297 – 305).
Modulation of the postprandial acid and bile pockets at the gastro-oesophageal junction by drugs that affect gastric motility
V. Boecxstaens et al. (Volume 33, Issue 12, Pages 1370 – 1377).
Systematic review: temporary stent placement for benign rupture or anastomotic leak of the oesophagus
P. G. A. van Boeckel et al. (Volume 33, Issue 12, Pages 1292 – 1301).
Epidemiology and practice patterns of achalasia in a large multi-centre database
B. K. Enestvedt J. L. Williams & A. Sonnenberg (Volume 33, Issue 11, Pages 1209 – 1214).
Dilated intercellular spaces and lymphocytes on biopsy relate to symptoms in erosive GERD but not NERD
R. A. Tadiparthi et al. (Volume 33, Issue 11, Pages 1202 – 1208).
Oesophageal eosinophilic infiltration in patients with noncardiac chest pain
S. R. Achem et al. (Volume 33, Issue 11, Pages 1194 – 1201).
Randomised clinical trial: the efficacy of a transient receptor potential vanilloid 1 antagonist AZD1386 in human oesophageal pain
A. L. Krarup et al. (Volume 33, Issue 10, Pages 1113 – 1122).
Randomised clinical trial: twice daily esomeprazole 40 mg vs. pantoprazole 40 mg in Barrett’s oesophagus for 1 year
N. de Bortoli et al. (Volume 33, Issue 9, Pages 1019 – 1027).
Gastric histology in children treated with proton pump inhibitors long term, with emphasis on enterochromaffin cell-like hyperplasia
E. Hassall et al. (Volume 33, Issue 7, Pages 829 – 836).
The effects of itopride on oesophageal motility and lower oesophageal sphincter function in man
E. Scarpellini et al. (Volume 33, Issue 1, Pages 99 – 105).
Review article: reflux and its consequences – the laryngeal, pulmonary and oesophageal manifestations
P. W. Dettmar et al. (Volume 33, Issue Supplement s1, Pages 1 – 71).